A-D
2 years ago-Biopharma Group
2 years ago-BioGenes GmbH

Congenital Birth Defects Following Use of Dydrogesterone Versus Micronised Vaginal Progesterone as Luteal Phase Support: A Retrospective, Observational Study

Views: 150

Incidence of congenital anomalies is reported to be higher in children born to couples with infertility compared to their fertile counterparts. Parental (chromosomal, genetic) and environmental factors are major contributory factors. In this study, Dr. Baidyanath Chakravarty et al. compare the incidence of congenital anomalies in babies born to infertile women with in-utero exposure to either dydrogesterone or micronised vaginal progesterone (MVP) following assisted reproductive technology (ART) and non-ART treatment, and in infertile women conceiving normally and not receiving any drug for luteal phase support (LPS).

Comments: 0

Your email address will not be published. Required fields are marked with *

0

Your Cart